BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29566103)

  • 1. The farm cost of decreasing antimicrobial use in dairy production.
    Lhermie G; Tauer LW; Gröhn YT
    PLoS One; 2018; 13(3):e0194832. PubMed ID: 29566103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An assessment of the economic costs to the U.S. dairy market of antimicrobial use restrictions.
    Lhermie G; Tauer LW; Gröhn YT
    Prev Vet Med; 2018 Nov; 160():63-67. PubMed ID: 30388999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic comparison of systemic antimicrobial therapies for metritis in dairy cows.
    Lima FS; Vieira-Neto A; Snodgrass JA; De Vries A; Santos JEP
    J Dairy Sci; 2019 Aug; 102(8):7345-7358. PubMed ID: 31178192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic and environmental feasibility of a perennial cow dairy farm.
    Rotz CA; Zartman DL; Crandall KL
    J Dairy Sci; 2005 Aug; 88(8):3009-19. PubMed ID: 16027215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cow-specific treatment of clinical mastitis: an economic approach.
    Steeneveld W; van Werven T; Barkema HW; Hogeveen H
    J Dairy Sci; 2011 Jan; 94(1):174-88. PubMed ID: 21183029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An observational cohort study on antimicrobial usage on dairy farms in Quebec, Canada.
    Lardé H; Dufour S; Archambault M; Massé J; Roy JP; Francoz D
    J Dairy Sci; 2021 Feb; 104(2):1864-1880. PubMed ID: 33272584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of meloxicam to the treatment of bovine clinical mastitis results in a net economic benefit to the dairy farmer.
    van Soest FJS; Abbeloos E; McDougall S; Hogeveen H
    J Dairy Sci; 2018 Apr; 101(4):3387-3397. PubMed ID: 29398019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial use on Canadian dairy farms.
    Saini V; McClure JT; Léger D; Dufour S; Sheldon AG; Scholl DT; Barkema HW
    J Dairy Sci; 2012 Mar; 95(3):1209-21. PubMed ID: 22365205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herd-level relationship between antimicrobial use and presence or absence of antimicrobial resistance in gram-negative bovine mastitis pathogens on Canadian dairy farms.
    Saini V; McClure JT; Scholl DT; DeVries TJ; Barkema HW
    J Dairy Sci; 2013 Aug; 96(8):4965-76. PubMed ID: 23769367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stakeholder position paper: dairy producer.
    Sischo WM
    Prev Vet Med; 2006 Feb; 73(2-3):203-8. PubMed ID: 16293327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of udder health parameters and risk factors for clinical mastitis in Dutch dairy herds in the context of a restricted antimicrobial usage policy.
    Santman-Berends IMGA; Swinkels JM; Lam TJGM; Keurentjes J; van Schaik G
    J Dairy Sci; 2016 Apr; 99(4):2930-2939. PubMed ID: 26874413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of generic clinical mastitis in dairy cows as estimated by using dynamic programming.
    Bar D; Tauer LW; Bennett G; González RN; Hertl JA; Schukken YH; Schulte HF; Welcome FL; Gröhn YT
    J Dairy Sci; 2008 Jun; 91(6):2205-14. PubMed ID: 18487643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of antimicrobial usage in adult cows and preweaned calves on 40 large Wisconsin dairy farms using dose-based and mass-based metrics.
    de Campos JL; Kates A; Steinberger A; Sethi A; Suen G; Shutske J; Safdar N; Goldberg T; Ruegg PL
    J Dairy Sci; 2021 Apr; 104(4):4727-4745. PubMed ID: 33551167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial use and farmers' attitude toward mastitis treatment on dairy farms with automatic or conventional milking systems.
    Deng Z; Lam TJGM; Hogeveen H; Spaninks M; Heij N; Postema M; van Werven T; Koop G
    J Dairy Sci; 2020 Aug; 103(8):7302-7314. PubMed ID: 32475666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the economic impact of subclinical ketosis in dairy cattle using a dynamic stochastic simulation model.
    Mostert PF; Bokkers EAM; van Middelaar CE; Hogeveen H; de Boer IJM
    Animal; 2018 Jan; 12(1):145-154. PubMed ID: 28637532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure and preventive costs of mastitis on Dutch dairy farms.
    van Soest FJS; Santman-Berends IMGA; Lam TJGM; Hogeveen H
    J Dairy Sci; 2016 Oct; 99(10):8365-8374. PubMed ID: 27474980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment practices and quantification of antimicrobial drug usage in conventional and organic dairy farms in Wisconsin.
    Pol M; Ruegg PL
    J Dairy Sci; 2007 Jan; 90(1):249-61. PubMed ID: 17183093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stochastic bio-economic modeling of mastitis in Ethiopian dairy farms.
    Getaneh AM; Mekonnen SA; Hogeveen H
    Prev Vet Med; 2017 Mar; 138():94-103. PubMed ID: 28237241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance of mastitis pathogens.
    Oliver SP; Murinda SE
    Vet Clin North Am Food Anim Pract; 2012 Jul; 28(2):165-85. PubMed ID: 22664201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobials use and their indications in dairy farm and individual farmer production conditions in southern India.
    Sharma D; Manimaran A; Kumaresan A; Sivaram M; Rajendran D
    Trop Anim Health Prod; 2021 Dec; 54(1):29. PubMed ID: 34962598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.